Clinical Trials Directory

Trials / Conditions / Geographic Atrophy Secondary to Age-related Macular Degeneration

Geographic Atrophy Secondary to Age-related Macular Degeneration

11 registered clinical trials studyying Geographic Atrophy Secondary to Age-related Macular Degeneration — 8 currently recruiting.

StatusTrialSponsorPhase
RecruitingSafety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy
NCT07531927
Okuvision GmbHN/A
RecruitingA Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atr
NCT07441642
Novartis PharmaceuticalsPhase 2
RecruitingAn Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People
NCT07392255
Complement TherapeuticsPhase 1 / Phase 2
RecruitingPhase 2 Study of ADX-038 in Participants With Geographic Atrophy
NCT06990269
ADARx Pharmaceuticals, Inc.Phase 2
CompletedStudy to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe
NCT07214740
Apellis Pharmaceuticals, Inc.Phase 3
RecruitingA Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
NCT07144137
Complement Therapeutics—
RecruitingA Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerab
NCT07215390
Apellis Pharmaceuticals, Inc.Phase 2
RecruitingA Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular De
NCT06765980
Kriya Therapeutics, Inc.Phase 1 / Phase 2
RecruitingMicrocurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
NCT06662162
i-Lumen Scientific AUS PTY LTDN/A
CompletedAn Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geo
NCT04770545
Apellis Pharmaceuticals, Inc.Phase 3
CompletedEvaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natu
NCT07424235
IRCCS Ospedale San Raffaele—